Biotech Industry

 
News Articles for Biotech Industry top ^
Presentation Scheduled for Friday, September 27 at 10:30 a.m. ET KANSAS CITY, Kan.
Sign-up for Aratana Therapeutics to Present at BioCentury's NewsMakers in the Biotech Industry Conference investment picks
2014/3/19
NEW YORK, March 19, 2014 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy industry, announced today that the Company will present at three sessions at the Alliance for Regenerative Medicine (ARM) 2nd Annual Regen Med Investor Day, to be held on March 26, 2014.
Sign-up for NeoStem to Present at ARM's Regen Med Investor Day and BioCentury's Future Leaders in the Biotech Industry Conference investment picks
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the BioCentury 20 th Annual NewsMakers in the Biotech Industry Conference in New York on Friday, September 27, 2013 at 8:30 a.m. ET.
Sign-up for NPS Pharmaceuticals to Present at NewsMakers in the Biotech Industry Conference investment picks
2014/3/21
DURHAM, N.C., March 21, 2014 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS) , a biopharmaceutical company focused on the development and commercialization of personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, today announced that Jeffrey Abbey, president and chief executive officer, will present at the upcoming 21 st Annual Future Leaders in the Biotech Industry conference.
Sign-up for Argos Therapeutics to Present at 21st Annual Future Leaders in the Biotech Industry Conference investment picks
2014/3/20
SAN DIEGO, March 20, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) , a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, today announced that Krisztina Zsebo, Ph.D., President and Chief Executive Officer, will present a corporate overview at the Future Leaders in the Biotech Industry conference, being held at the Millennium Hotel in New York city on Friday, March 28, 2014.
Sign-up for Celladon to Present at BioCentury's Future Leaders in the Biotech Industry Conference investment picks
2014/3/20
CHAPEL HILL, N.C., March 20, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP) today announced that Prabhavathi Fernandes, Ph.D., chief executive officer of Cempra, will present at The 21 st Annual Future Leaders in the Biotech Industry Conference at 11:30 a.m. EDT, Friday, March 28, at the Millennium Broadway Hotel & Conference Center in New York City and at the Needham & Co.
Sign-up for Cempra, Inc. to Present at The 21st Annual Future Leaders in the Biotech Industry Conference and Needham & Co. 12th Annual Healthcare Conference investment picks
2014/3/20
BASKING RIDGE, N.J. , March 20, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO) , a biopharmaceutical company focused on the late-stage, Phase 3 clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced that it will present at the 21 st Annual Future Leaders in the Biotech Industry Conference taking place on March 28, 2014 , at the Millennium Broadway Hotel & Conference Center in New York City .
Sign-up for Regado Biosciences to Present at the 21st Annual Future Leaders in the Biotech Industry Conference investment picks
2014/3/20
BOSTON, March 20, 2014 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP) today announced that Francois Lebel, M.D., Senior Vice President, Clinical Development and Medical Operations, will present at the 21 st Annual Future Leaders in the Biotech Industry Conference on Friday, March 28th, 2014 at 3:00 p.m. ET at the Millennium Broadway Hotel in New York City.
Sign-up for ZIOPHARM Oncology to Present at the 21st Annual Future Leaders in the Biotech Industry Conference investment picks
Live Webcast from New York on Friday, September 27 SAN DIEGO , Sept.
Sign-up for MEI Pharma to Present at BioCentury's NewsMakers in the Biotech Industry Conference investment picks
2014/3/21
SEATTLE , March 21, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) , a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that Gregory A.
Sign-up for Omeros to Present at BioCentury Future Leaders in the Biotech Industry Conference investment picks
2014/3/20
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced its participation at the 21 st Annual Future Leaders in the Biotech Industry Conference to be held on March 28, 2014 at the Millennium Broadway Hotel & Conference Center in New York City.
Sign-up for Acceleron to Present at the 21st Annual Future Leaders in the Biotech Industry Conference investment picks
REDWOOD CITY, Calif., Sept.
Sign-up for OncoMed Pharmaceuticals to Present at BioCentury's NewsMakers in the Biotech Industry Conference investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1052553&ProfileId=051205&sourceType=1 DEERFIELD, IL --
Sign-up for Horizon Pharma to Present at the 20th Annual NewsMakers in the Biotech Industry Conference investment picks
CHAPEL HILL, N.C., Sept.
Sign-up for Cempra, Inc. to Present at NewsMakers in the Biotech Industry Conference investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Biotech Industry
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Biotech Companies  |  Next: Biotech Industry Conference